Ms. Kanij Ansari et al. 2026. Designed 1-Hydroxynaphthalene-2-Carboxanilide Derivatives were evaluated for their Anticancer drug candidate properties by performing a Silico Pharmacokinetic and Silico Toxicological Analysis. The Bioscan. 21, 3 (Jul. 2026), 139–153.